
SocialGenomics is a technology company focused on accelerating medical breakthroughs and treatments for rare genetic diseases and cancers. Leveraging advanced AI algorithms and deep learning, the platform connects patients with similar gene mutations to facilitate mutual support and accelerate research. For researchers, SocialGenomics offers a tool to easily find, recruit, and communicate with study participants, streamlining informed consent and providing data analytics. The company's mission is to make life-saving information and treatments accessible and affordable globally, ultimately transforming patient lives and reducing healthcare costs.

SocialGenomics is a technology company focused on accelerating medical breakthroughs and treatments for rare genetic diseases and cancers. Leveraging advanced AI algorithms and deep learning, the platform connects patients with similar gene mutations to facilitate mutual support and accelerate research. For researchers, SocialGenomics offers a tool to easily find, recruit, and communicate with study participants, streamlining informed consent and providing data analytics. The company's mission is to make life-saving information and treatments accessible and affordable globally, ultimately transforming patient lives and reducing healthcare costs.